Article By:
Jim Van Meerten
Tuesday, February 27, 2024 5:15 AM EDT
ADC Therapeutics SA, a commercial-stage biotechnology company, develops antibody drug conjugates for patients suffering from hematological malignancies and solid tumors.
In this article: ADCT
